Φορτώνει......
A role of peroxisome proliferator‐activated receptor γ in non‐alcoholic fatty liver disease
Non‐alcoholic fatty liver disease is becoming a major health burden, as prevalence increases and there are no approved treatment options. Thiazolidinediones target the nuclear receptor peroxisome proliferator‐activated receptor γ (PPARγ) and have been investigated in several clinical trials for thei...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Basic Clin Pharmacol Toxicol |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley and Sons Inc.
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6850367/ https://ncbi.nlm.nih.gov/pubmed/30561132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcpt.13190 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|